NEU neuren pharmaceuticals limited

Ann: NEU confirms primary endpoints for Phase 3 trial in PMS, page-161

  1. 2,499 Posts.
    lightbulb Created with Sketch. 681
    I think paying out the excess cash to shareholders in the event of a TO transaction makes sense. This would be on top of whatever the theoretical offer price is. The acquirer is most likely going to be from the US or EU, so holding a company with the franking credits doesn't make a lot of sense for them and presumably they will transfer the IP to themselves and shut down the company if there's no financial reason to keep it around. The other aspect is sometimes these type of transactions can be classed as capital returns, rather than dividends but I don't know the ins and outs there. A recent example is Suncorp (when they sold their banking business to ANZ).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.10
Change
-0.800(5.76%)
Mkt cap ! $1.629B
Open High Low Value Volume
$13.95 $13.96 $12.88 $9.534M 725.6K

Buyers (Bids)

No. Vol. Price($)
1 266 $13.10
 

Sellers (Offers)

Price($) Vol. No.
$13.15 1619 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.